THALASSEMIA: A REVIEW
Journal Title: Asian Journal Of Pharmaceutical Research and Development - Year 2017, Vol 5, Issue 3
Abstract
The thalassemia is a group of inherited hematologic disorders caused by defects in the synthesis of one or more of the hemoglobin chains. Alpha thalassemia is caused by reduced or absent synthesis of alpha globin chains, and beta thalassemia is caused by reduced or absent synthesis of beta globin chains. Imbalances of globin chains cause hemolysis and impair erythropoiesis. Silent carriers of alpha thalassemia and persons with alpha or beta thalassemia trait are asymptomatic and require no treatment. Alpha thalassemia intermedia, or hemoglobin H disease, causes hemolytic anemia. Alpha thalassemia major with hemoglobin Bart's usually results in fatal hydropsfetalis. Beta thalassemia major causes hemolytic anemia, poor growth, and skeletal abnormalities during infancy. Affected children will require regular lifelong blood transfusions. Beta thalassemia intermedia is less severe than beta thalassemia major and may require episodic blood transfusions. β-Thalassemia and sickle cell disease both display a great deal of phenotypic heterogeneity, despite being generally thought of as simple Mendelian diseases. The reasons for this are not well understood, although the level of fetal hemoglobin (HbF) is one well characterized ameliorating factor in both of these conditions. The globin gene disorders including the thalassemias are among the most common human genetic diseases with more than 300,000 severely affected individuals born throughout the world every year. Because of the easy accessibility of purified, highly specialized, mature erythroid cells from peripheral blood, the hemoglobinopathies were among the first tractable human molecular diseases.
Authors and Affiliations
Ankit Kumar Kumawat,
Keywords
Related Articles
- EP ID EP303257
- DOI -
- Views 100
- Downloads 0
OVER REVIEW ON POTENTIAL USE OF HYDROGEL IN CANCER TREATMENT
In this review study was carried out to focus on uses of hydrogels in cancer treatment. hydrogel has unique property due to which it has played a vital role in controlled-release drug delivery systems. A hydrogel has pr...
GASTRO RETENTIVE – FLOATING DRUG DELIVERY SYSTEM AN OVERVIEW
Drug efficacy, minimal frequency of administration and bioavailability are the major concern of every new drug development and formulation, the research is going on for existing drug novelty for above said. To achieve th...
FORMULATION AND EVALUATION OF KETOCONAZOLE NIOSOMAL GEL
In recent years, treatment of infectious disease through Novel Drug delivery system (NDDS) has undergone a revolutionary shift. Niosomes are a Novel Drug Delivery system which has potential application to...
FORMULATION AND EVALUATION OF ITRACONAZOLE NIOSOMAL GEL
The present study was to formulate and evaluate the Itraconazole niosomal gel using surfactant span 40 and span 60 for the preparation of niosomes. The main objective of the study was to enhance the antifung...
ANALYTICAL METHOD DEVELOPMENT, VALIDATION AND FORCED DEGRADATION STUDIES OF LANSOPRAZOLEBY RP-HPLC
The objective of this work is to develop a rapid, precise, accurate and sensitive revere phase liquid chromatographic method and Forced degradation studies for the estimation of Lansoprazole. Th...